Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.14
+0.17 (0.90%)
At close: Mar 9, 2026, 4:00 PM EDT
19.48
+0.34 (1.78%)
After-hours: Mar 9, 2026, 7:57 PM EDT
Legend Biotech Revenue
Legend Biotech had revenue of $272.33M in the quarter ending September 30, 2025, with 69.99% growth. This brings the company's revenue in the last twelve months to $909.05M, up 74.75% year-over-year. In the year 2024, Legend Biotech had annual revenue of $627.24M with 119.97% growth.
Revenue (ttm)
$909.05M
Revenue Growth
+74.75%
P/S Ratio
3.89
Revenue / Employee
$348,427
Employees
2,609
Market Cap
3.53B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ACADIA Pharmaceuticals | 1.07B |
| Corcept Therapeutics | 761.41M |
| ADMA Biologics | 510.17M |
| Tarsus Pharmaceuticals | 451.36M |
| NewAmsterdam Pharma Company | 22.50M |
| Centessa Pharmaceuticals | 15.00M |
| Xenon Pharmaceuticals | 7.50M |
LEGN News
- 7 days ago - Artisan International Small-Mid Fund Q4 2025 Performance Review - Seeking Alpha
- 5 weeks ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 7 weeks ago - Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 3 months ago - Cancer Study Buoys These Small Biotechs - Barrons
- 3 months ago - Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025 - GlobeNewsWire
- 3 months ago - Legend Biotech: Is Carvykti Changing Cancer Treatment Forever? - Seeking Alpha
- 4 months ago - Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - GlobeNewsWire